A randomized, open-label, clinical trial to study the effect of lixisenatide vs. exenatide on metabolic control, insulin secretion and insulin sensitivity in patients with impaired glucose tolerance .
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2015
At a glance
- Drugs Lixisenatide (Primary) ; Exenatide
- Indications Glucose metabolism disorders
- Focus Pharmacokinetics
- 27 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.